ArticleInternational journal of hematology2026

Efficacy of polatuzumab vedotin versus conventional chemotherapy in relapsed or refractory diffuse large B-cell lymphoma.

Tatsuzo Mishina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.